Related Experiment Video

Updated: Sep 11, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

525

Population-Level Gaps in Coronary Artery Disease Care: A Focused Review

Aleesha Kainat1, Asad R Natique2, Anum Saeed3

  • 1Division of General Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, US.

Methodist Debakey Cardiovascular Journal
|August 18, 2025
PubMed

Insights

Racial disparities in coronary artery disease (CAD) persist despite advances. Factors beyond traditional risks, like healthcare access and socioeconomic status, contribute to these inequities, necessitating focused efforts for cardiovascular care equity.

Area of Science:

  • Cardiovascular Medicine
  • Health Disparities Research
  • Public Health

Background:

  • Coronary artery disease (CAD) remains a leading cause of mortality.
  • Significant racial and ethnic disparities exist in CAD prevalence, treatment, and outcomes.
  • Traditional cardiovascular risk factors do not fully explain these observed inequities.

Purpose of the Study:

  • To examine the multifaceted factors contributing to racial disparities in coronary artery disease.
  • To highlight the impact of healthcare access, socioeconomic status, and environmental factors on CAD inequities.
  • To underscore the need for research and clinical trial inclusivity for minority populations.

Main Methods:

  • This study synthesizes existing research on CAD disparities.
  • Analysis incorporates data on traditional risk factors, socioeconomic determinants, and healthcare access.
  • Literature review focuses on underrepresented minority populations in cardiovascular research.

Main Results:

  • Racial subgroups exhibit substantial differences in CAD incidence and outcomes.
  • Healthcare access, socioeconomic status, and environmental context significantly influence these disparities.
  • Minority populations are underrepresented in cardiovascular research, limiting understanding of unique needs.

Conclusions:

  • Addressing racial disparities in CAD requires a comprehensive approach beyond traditional risk factor management.
  • Improving healthcare equity and socioeconomic conditions is crucial for reducing CAD inequities.
  • Increased inclusion of diverse populations in research is essential for advancing cardiovascular care for all.

Keywords:
cardiovascular disease carehealth equityhealthcare disparitiesracial and ethnic disparitiessocial determinants of health

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.6K
Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

844

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
32